Momenta Pharmaceuticals Inc. (MNTA) Tops Q1 EPS by 22c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Financial Fact:
General and administrative: 15.76M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
General and administrative: 15.76M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) reported Q1 EPS of $1.13, $0.22 better than the analyst estimate of $0.91, and well above Q1:10 result of a loss of $0.37. Revenue for the quarter came in at $78.2 million versus the consensus estimate of $67.12 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
Create E-mail Alert Related Categories
Earnings, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
